(Photo : Lachlan Cunningham/Getty Images for Breakthrough Prize)
Mark Zuckerberg (L) and Priscilla Chan attend the 2019 Breakthrough Prize at NASA Ames Research Center on November 4, 2018 in Mountain View, California.

The Chan Zuckerberg Initiative (CZI), headed by Mark Zuckerberg and Priscilla Chan, aims to eliminate all illnesses by the end of 2100. The charitable organization thinks artificial intelligence (AI) will be crucial in reaching this enormous goal.

Mark Zuckerberg voiced excitement at the announcement about the promise of AI in the areas of disease prevention, management, and cures. He emphasized how AI may help researchers understand how cells interact with one another both individually and collectively inside biological creatures, per NDTV.

CZI Co-Founder and Co-CEO Mark Zuckerberg remarked that AI is developing "new opportunities in biomedicine" that will "accelerate progress" in a deeper understanding of the functions of cells.

A Massive Undertaking

According to Mashable, The CZI project's first AI-powered program is referred to as the "Virtual Cell." The goal of this initiative is to help researchers develop a thorough map of the many stages of both healthy and sick cells during the course of their life cycles. The Chan Zuckerberg Initiative is building one of the largest AI computing clusters to support this massive project.

By referencing the creation of single-cell datasets by researchers at their institution, Priscilla Chan, a former pediatrician, underscored the significance of data in this endeavor. Over a thousand GPUs (Graphics Processing Units) will be present in the AI-driven computing cluster. This infrastructure will make it possible to create computer models that can identify the sorts of cells found in a genome and forecast how immune cells would react to infectious diseases.

The Chan Zuckerberg Institute for Advanced Biological Imaging's computer system will be trained to utilize datasets from CZ Cell x Gene software tools, Chan Zuckerberg Biohub Network resources, and publicly accessible data. When finished, this computer system will rank among the biggest AI clusters for non-profit study.

Although CZI began funding local community and educational initiatives in San Francisco in 2015, this new project represents a big step into biotechnology. According to Business Insider, the program complements other initiatives like Meta's development of ESMFold, an AI tool built to effectively forecast protein shapes using AI methods similar to those envisioned for CZI's database.

Read Also: Surging Obesity Rates in US Raise Alarm: 22 States Hit 35% or Higher, Says CDC

The innovative protein-folding predictions made by ESMFold, which is said to be a quicker version of AlphaFold, have important ramifications for biology and medicine.

Elon Musk's Neuralink Starts PRIME Study

This CZI news comes in the wake of Neuralink's recent achievement in getting FDA clearance and starting patient enrollment for its PRIME Study. Tech mogul Elon Musk launched the neurotech business, which focuses on brain implant technology to empower people with severe paralysis by giving them the ability to control external objects via neurological impulses.

In order to further its research, Neuralink will perform invasive brain surgery on PRIME Study participants.

This groundbreaking experiment may involve cervical spinal cord injury and ALS patients, as previously reported by TechTimes. Though the business does not indicate the number of participants, the experiment will last six years. Robots will help implant brain-computer interface (BCI) devices throughout the duration of the study.

Tech mogul Elon Musk has outlined grandiose plans for Neuralink, including quick surgical implantations of chip devices to cure disorders including obesity, autism, melancholy, and schizophrenia.

Related Article: Second Patient Receives Genetically Altered Pig Heart for End-Stage Heart Disease